The Artemi Team
Dr. Peter Seeberger
Founder & CEO
ArtemiFlow GMbH
Peter H. Seeberger is an academic (professor at MIT, ETH, MPI) co-inventor of more than 60 patent families and serial entrepreneur with 30+ years drug discovery experience. Ancora Pharmaceuticals and Vaxxilon were successfully sold while Draupnir Bio, Tacalyx, and several other companies are still growing.
Dr. Kerry Gilmore
Shareholder & COO
ArtemiFlow USA, ArtemiLife™️, ArtemiPet™️
Kerry Gilmore is currently an Assistant Professor at UConn. He has researched pharmaceutical manufacturing and applications of artemisinin for over a decade. He holds eight patents and has published more than 50 peer-reviewed publications.
Adam Maust
Shareholder & CEO
ArtemiFlow USA, ArtemiLife™️, ArtemiPet™️
Adam Maust has nearly 20 years of experience across a wide spectrum of projects and industries involving 10’s of millions of dollars and has led to receiving multiple national awards for the creative impact and innovative in those efforts. Over the last 5 years for Artemi he has developed and managed the products, processes, branding, trials and research.
Dr. Stephan Deblon
Shareholder
IP Consultant
Stephan Deblon is a German and European Patent attorney with 20+ years experience in IP creation, defence, enforcement and licensing. He further was and is responsible for IP related aspects in numerous M&A transactions with volumes of up to several billion USD.